Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia. (Q54330255)
Jump to navigation
Jump to search
scientific article published on 9 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia. |
scientific article published on 9 January 2012 |
Statements
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia. (English)
H Pfeifer
T Lange
S Wystub
B Wassmann
J Maier
A Binckebanck
A Giagounidis
M Stelljes
M Schmalzing
U Dührsen
L Wunderle
P Brück
A Schmidt
D Hoelzer
9 January 2012
26
7
1475-1481
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference